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The biliary tree is the final pathway as well as an
access site to most of the major organs in the
hepatobiliary and pancreatic system. As such the
biliary tree is often the first to manifest disorders of
the liver, pancreas, gallbladder and duodenum and
often the most convenient access to these organs. This
year’s meeting emphasized minimally invasive techni-
ques, more sophisticated surveillance, early detection
and quality of care with better surgical outcomes.
Dr Henry Pitt (USA), the outgoing president of the
IHPBA, stressed the concerning problem of obesity
worldwide. Dr Pitt emphasized that our diet and
sedentary activities have a direct bearing on biliary
stones, fatty livers and pancreas, increasing the
difficulty in surgical approaches. Dr Palepa Jagannath
(India) presented the largest population-based study
in the field of HPB surgical diseases. He identified the
Ganges catchment area as having an association of
carcinoma of the gallbladder and environmental
contamination with heavy metals. He emphasized
that this is a world concern, especially in the third
world where there are more lenient environment
regulations. A second large population-based study
by Yuji Nimura (Japan), discussed intrahepatic cho-
langiocarcinoma. Dr Nimura stressed the difficulty in
accurately staging intrahepatic cholangiocarcinoma
and that anatomical considerations alone are probably
insufficient for accurate prognosis and that the
morphology and biobehaviour of the tumour are
probably more important for prognosis. He stressed
that R0 resection for intrahepatic cholangiocarcino-
mas can usually be achieved by en bloc techniques.
The IHPBA sponsored a symposium on approaches
to gallbladder cancer. The three presenters were
Xabier Arextabala (Chile), Bill Jarnigan (USA) and
Masura Miyazaki (Japan). Gallbladder cancer remains
a lethal malignancy in the hepatobiliary tree and
appears to have an increasing frequency. There are
still multiple areas of controversy regarding staging
and resectability and selection of patients. An im-
portant point is that preoperative suspicion of gall-
bladder cancer is crucial for appropriate, timely and
effective management of this malignancy. Retrospec-
tive reviews showed that a tumour of the gallbladder
could be diagnosed by the radiologist in more than
half the cases on ultrasound. This should then change
the approach from a laparoscopic cholecystectomy to
more of an oncologic approach, with staging and
imaging in preparation for resection if malignancy can
be identified preoperatively. There was universal
agreement that partial dissection, incomplete resec-
tion, or an unprepared patient were important nega-
tive factors in successful management of gallbladder
cancer. The authors stressed that the surgeon must
personally look at the images before carrying out
cholecystectomy. If a tumour is suspected, laparo-
scopic staging is useful in identifying metastases,
associated liver disease or other signs that would
preclude operative intervention. The presenters felt
that gallbladder cancer is resectable only in stages
IIII, that stage IV has a poor prognosis and the
patients are palliative, and that major surgery has little
value. There was controversy regarding the type of
operation that should be performed for resectable
gallbladder cancers. Although the lymph nodes
should be removed for prognostic evaluation, there
does not appear to be a surgical advantage for radical
lymphadenectomy. The same can be said for the
hepatic duct. Resection of the lymph nodes and the
bile duct may add significantly to the surgical proce-
dure; however, resection and reconstruction of the
bile duct have not been clearly shown to have a
survival advantage. It was therefore agreed that if the
gallbladder cancer is present near the cystic duct and
in the apex of the triangle of Calot and resection of the
bile duct is necessary for clearance then bile duct
resection would seem prudent. If the tumour was
close to the right hepatic duct, a more extensive liver
resection may be necessary so as to include the right
hepatic duct and surrounding tissue. A less radical
liver resection may be necessary if the tumour was at
the fundus of the gallbladder with minimal invasion of
the liver. There was general consensus that the type of
liver resection for resectable gallbladder cancer is still
not clear. In summary, this symposium suggests that
preoperative suspicion is the most important aspect of
appropriate management. Once identified, a cautious
approach to the gallbladder after an oncological work-
up is advisable, so that the surgeon is prepared for
either cholecystectomy or a more radical resection if
needed. It is most prudent that for stages IB, II and III
beyond the mecosa of the gallbladder resection of the
gallbladder cancer is appropriate. The type of surgery
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is yet to be clarified because of the lack of prospective
randomized trials.
Certain abstracts were highlighted as interesting to
the majority of hepatobiliary surgeons and presented
new and enlightening data. One such abstract addres-
sing duodenal invasion secondary to gallbladder
cancer was written by Agarwal et al. (New Delhi,
India). This was a prospective trial of 252 patients.
This impressive series demonstrated that duodenal
infiltration of the gallbladder carcinoma is not a
contraindication for resection and can usually be
performed with the addition of a partial or segmental
duodenectomy with primary reconstruction. How-
ever, if the patient has jaundice secondary to common
bile duct invasion, resection is almost never possible
for curative intent.
A symposium on bile duct injuries included
Steven Strasberg (USA), Yaman Tekant (Turkey),
James Garden (UK) and Eduardo de Santibanes
(Argentina). All authors presented large interesting
series and the highlights of their presentations em-
phasized prevention as the ultimate goal. The term
‘critical view’, popularized by Dr Strasberg, is gaining
wider appreciation and acceptance in the surgical
community as a critical step in preventing the
misidentification of the anatomy in the triangle of
Calot. Dr Garden emphasized that sepsis, vascular
injury and delayed recognition are associated with
very poor outcomes. If your patient is not getting
better after 2448 h, a bile duct injury must be ruled
out if the patient has undergone a laparoscopic
cholecystectomy. Progress in metal stenting for even
severe bile duct structuring is finding a place. There is
increasing evidence that ‘covered’ expandable metal
stents, which are removable, may be appropriate in
stenting bile duct injuries as an alternative to transhe-
patic percutaneous stenting for severe bile duct
strictures. Dr Eduardo de Santibanes noted that the
initial management of a bile duct stricture is the most
critical step in the prevention of long-term complica-
tions such as secondary biliary cirrhosis, portal
hypertension and the need for a liver transplant. He
emphasized that if a bile duct injury is identified it
should be sent to or repaired by an experienced
surgeon, who is familiar with bile duct reconstruction.
There was an alternative opinion that fundus down
may be as safe as initial identification of the structures
of the triangle of Calot. Opinions were equally
defended. Surgeons from Europe and North America
tended to believe that the critical view is most
appropriate before proceeding, whereas South-Asian
surgeons felt that the fundus down approach was the
safest. There was no agreement as to technique at the
end of the discussion.
There were several interesting abstracts addressing
bile duct injuries. Fiocca et al. (Rome) described a
minimally invasive treatment for even complete
transection of the main bile duct. Their technique
involved a combined ERCP and interventional radi-
ology approach, in which the endoscopic surgeon
retrieves the wire pass percutaneously through the
liver where a covered expandable metal stent can be
railroaded beyond the two ends of the bile duct,
allowing the bile duct to heal. They reported a higher
rate of success for this procedure; however, this series
was relatively small and spread out over a number
of years, although their experience is increasing.
Ramos et al. from the Mayo Clinic reported on the
clinic’s experience with stricture dilation of benign
biliary strictures. They reported an approximately
70% success rate with benign biliary strictures
that can be fully dilated, and that both endoscopic
and radiological approaches still have a place in
treating benign biliary strictures. Dr de Santibanes
(Argentina) reported his experience in dealing with
benign biliary bile duct injuries by posterior right
sectionectomy and hepaticojejunostomy. This techni-
que describes the approach to the posterior sector bile
duct from the right side and similar approach to
the contralateral side in a segment II/III bypass. With
the ability to approach both sides of the liver in this
fashion, high and complex bile duct injuries can be
addressed surgically.
The subject of challenging biliary strictures was
addressed by a symposium of four presenters
and moderators: Xuegueng Zhu (China), Steve
Ahrendt (USA), Surendra Kumar Mathur (India)
and Philippus Bornman (South Africa). Despite this
problem having been addressed in many meetings in
the past, several interesting findings arose from the
symposium. Dr Zhu reported that despite the
modernization of China, recurrent pyogenic cholan-
gitis (RPC) and intrahepatic ductal lithiasis is not
disappearing; however, it is being recognized at an
earlier and more treatable stage. The reason why this
is not disappearing is still not clearly understood.
Despite early identification of RPC in its earlier
stages, minimally invasive surgery does not seem to
control it and resection is often still necessary. Dr
Kumar (India) described an impressive series of
tubercular strictures of the biliary tree. This rare
diagnosis is seldom made unless tuberculosis is
considered as a possible cause. The approach to bile
duct stricturing is multidisciplinary but stenting is
often necessary to maintain biliary patency during
antibiotic therapy. Dr Ahrendt (USA) presented his
extensive series in the multimodality approaches to
dominant strictures in primary sclerosing cholangitis.
The important lessons demonstrated by his series are
that the initial stricture is often the malignant one, and
that dominant stricture management by stricture
dilation is frequently the best approach. Patients
require close surveillance to prevent secondary biliary
cirrhosis and ultimately liver transplant. Dr Bornman
(South Africa) discussed bile duct strictures in
chronic pancreatitis and recommended that benign
pancreatic strictures rarely need stenting; if they
are stented you often commit your patient to chronic
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stenting as pancreatic bile duct strictures seldom
resolve. They never resolve if the pancreas is calci-
fied, thus his recommendation is not to stent benign
pancreatic strictures unless they are complicated.
Dr Parks (UK) discussed preoperative biliary drainage
and whether this is appropriate or not. Still, despite
multiple trials to try and clarify this question, there
does not appear to be a physiological reason for
preoperative biliary drainage. It is associated with
increased sepsis postoperatively and the bile duct
probably should not be stented unless the patient
cannot tolerate the pruritus. Most patients are diag-
nosed at the time of the ERCP and the contaminated
bile requires drainage. An update on cholangiocarci-
noma by Pierre-Alain Clavien of Switzerland showed
that there is an apparent wordwide increase in
cholangiocarcinoma and that the staging, clarification
and surgical approaches are significantly enhanced by
PET-CT. PET-CT has/90% sensitivity in detecting
bile duct cancer; however, the lack of PET-CT
facilities is still a major challenge for surgeons in
accurate staging and mapping of this difficult tumour.
Laparoscopic common bile duct exploration was
discussed by Dr Nathanson (Australia). Dr Nathan-
son’s experience is significant in this area and he
reports that transcystic duct exploration is the most
appropriate when possible, and it is possible in the
majority of patients with small common duct stones.
Laparoscopic exploration of the common duct using a
choledochotomy is challenging and should be per-
formed by experienced surgeons; he cautions sur-
geons about approaching a common duct that is
not dilated more than 8 mm as there is a risk of
stricturing.
Dr Thomas van Gulik (Netherlands) and Dr
Charles Rosen (USA) debated resection or trans-
plantation for cholangiocarcinoma. It was agreed
that surgery has likely maxed out its effectiveness.
TheB/50% long-term survival rate is more likely one-
third and these patients often have favourable tu-
mours. In Dr Rosen’s series, now over 80 patients
with an aggressive chemotherapeutic and radiation
programme have/50% long-term survivorship for
non-resectable cholangiocarcinomas due to either
non-resectability of the tumour or significant comor-
bid liver disease. These results are superior to surgical
resection in highly selected patients. The challenge
is organ availability for these patients. Drs Padbury
and Palmer from Australia and the UK, respectively,
argued local excision versus Whipple procedure for
small ampullary lesions. The consensus was that
benign simple lesions should be resected by endo-
scopic ampullectomy and that severe dysplasia prob-
ably means cancer and Whipple’s resection is the most
appropriate. This leaves surgical ampullectomy with
few indications.
Macrobiotic preparations for patients with cancer
seems to be gaining favour in many countries. Nagino
et al. (Japan) described a synbiotic treatment to
prevent postoperative infections complicating biliary
tract cancer surgery. This was a randomized trial
favouring the synbiotic diet. Dr Pattison (UK) noted
that nutritional risk index predicts a high risk of
postoperative complications for patients with obstruc-
tive jaundice. Whether this can be altered preopera-
tively still remains a challenge. Abstracts discussing
the surgical management of severe acute cholecystitis
still reflect a controversy regarding delayed or early
surgical treatment for acute cholecystitis. Dr Jenkins
(UK) emphasized that the need for open cholecys-
tectomy still remains, that this should not be con-
sidered a surgical complication. Dr Hadad (UK)
reported that delay increases the conversion rate in
laparoscopic cholecystectomy for acute cholecystitis.
However, Dr Tzovara (Greece) reported in a pro-
spective study that delay does not seem to alter the
conversion rate for acute cholecystitis.
Malpractice litigation for bile duct injuries is still a
concern for the hepatobiliary surgeon. Drs de Reuver
and Gouma (Netherlands) report that litigious pa-
tients do not resolve their symptoms secondary to bile
duct injury until a settlement is in place.
Further discussions involving cholangiocarcinomas
are showing improved survival. Three abstracts pre-
sented by Dr Quyn (UK) showed that the addition of
photodynamic therapy appears to improve survival for
cholangiocarcinoma. Dr Cleary et al. (USA) showed
that surgical excision of proximal cholangiocarcino-
mas can be successful with a high number of patients
with good long-term results. Dr Nishio et al. from
Nagoya, Japan, discussed trisectionectomy for hilar
cholangiocarcinoma, showing that although more
tumours can be excised, the success rate in dependent
on background liver disease and that there are more
complications with a larger resection.
Dr Kang et al. (Korea) discussed inflammatory
pseudotumour of the liver mimicking a cholangiocar-
cinoma. Pseudotumours in the gallbladder area and
porta are not common but are seen by hepatobiliary
surgeons and should be considered as they do
not require surgical removal. They tend to resolve
on their own. Dr Urakami et al. (Japan) reported that
bile duct injuries in Japan have the same frequency as
in North America and Europe. This was a relief to
many.
Dr Ha et al. (Hong Kong, China) and Dr Alhamdani
(UK) both gave abstracts on primary bile duct closure
versus T-tube drainage after laparoscopic common
duct exploration. In this prospective randomized trial
from China, primary closure was generally thought to
be appropriate once the bile duct is clear. These
findings were echoed by Dr Alhamdani.
Improvements in laparoscopic technology have
led to more and more major hepatobiliary proce-
dures being done laparoscopically. Dr Jang et al.
(Korea) demonstrated a resection of choledochal
cyst laparoscopically with reconstruction using
a four-hole technique. Dr Toyota et al. (Japan)
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discussed their series on the treatment of acute
cholecystitis by placing a naso-biliary catheter within
the gallbladder and draining it this way rather
than surgical interventions for high-risk patients. Dr
Karigiri et al. (UK) discussed the need for early
ERCP after cholecystectomy, showing that ERCP can
be used after cholecystectomy, even in patients with
recognized common bile duct stones.
In summary, several themes through the meeting
suggested the use of aggressive surgical procedures.
However, if surgical aggression is matched by a low
complication rate and high degree of resectability, this
would seem appropriate management for a particular
malignancy and the term aggressive surgery should
probably be substituted by appropriate R0, en bloc or
complete resection. Further, surgical experience,
skill sets and patient care factors in the highly
technical area of hepatobiliary and pancreatic surgery
are creating recognition of HPB as a subspecialty
within surgery. There were symposia at this meeting
discussing the merits of specialized teaching pro-
grammes and fellowships for HPB to be formalized
so that a curriculum of knowledge and a skill set can
be developed that would be broadly applied for
trainees in HPB surgery. This would decrease the
learning curve and increase exposure of trainees to
this complex surgery. Lastly, the meeting suggested a
systems approach to HPB surgery. However, it is
clear that multimodality management requires multi-
ple individual skills such as laparoscopic, endoscopic
and open surgical techniques all being performed
by a single person. This allows for better commu-
nication with other specialties, thus making the
interdisciplinary and multiple disciplinary expertise
readily available and the formation of the HPB
multimodality team would likely improve patient
management.
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New insights in surgical pancreatology
JAKOB IZBICKI
This review focuses on surgical pancreatology and
major issues discussed at the IHPBA Meeting 2006
in Edinburgh. The main topics and new studies
regarding surgical pancreatology presented at the
meeting were probiotics in acute pancreatitis (AP),
delayed gastric emptying, technical feasibility studies,
spleen-preserving distal pancreatectomy, distal pan-
createctomy, endoscopic sphincterotomy (ES) prior
to pancreatoduodenectomy (PD), survival in pancrea-
tic cancer, vessel invasion and vascular resection,
advanced tumours, pancreatic resection for metastatic
adenocarcinoma and hepatic resection in pancreatic
cancer.
Lutgendorff and colleagues described how infection
of pancreatic necrosis is caused by small bowel
bacterial overgrowth and increased intestinal perme-
ability. In an experimental rat model used by
van Minnen and co-workers, prophylactic probiotics
reduced bacterial translocation and late mortality.
Therefore probiotics might be a potential new
therapeutic approach to limit disease progression
in patients with infected pancreatic necrosis. This
is certainly a new approach deserving more atten-
tion.
Delayed gastric emptying was significantly reduced
by antecolic versus retrocolic reconstructions of
duodenojejunostomy in pylorus-preserving pancrea-
toduodenectomy (PPPD). Yamaue and colleagues
also described a reduction of postoperative morbidity,
length of presence of a nasogastric tube and a lower
hospital duration time.
In technical feasibility studies, modified pancreati-
cogastrostomy in PPPD with an isoperistaltic gastric
tube was created along the greater curvature of the
stomach. No leakage of pancreatic secretions was
detected in this trial by Costa and Lucas.
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